Quarterly Results

  • Company Name :
Neuland Laboratories Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 524558
  • NSE Symbol:
  • NEULANDLAB
  • P/E(TTM):
  • 114.12
  • ISIN Demat:
  • INE794A01010
  • Div & Yield%:
  • 0.07
  • EPS(TTM):
  • 151.95
  • Book Value(₹):
  • 1,255.94
  • Market Cap(₹Cr.):
  • 22,247.93
  • Face Value(₹):
  • 10.00
Quarters :  
Particulars September 2025 ( Cr)June 2025 ( Cr)March 2025 ( Cr)
Gross Sales 514.27 292.75 328.36
Excise Duty 0.00 0.00 0.00
Net Sales 514.27 292.75 328.36
Other Operating Income 0.00 0.00 0.00
Other Income 1.80 7.86 7.46
Total Income 516.07 300.61 335.82
Total Expenditure 359.15 258.46 277.61
PBIDT 156.92 42.15 58.22
Interest 5.34 4.58 2.35
PBDT 151.58 37.57 55.87
Depreciation 22.54 20.19 16.89
Tax 32.51 4.37 5.94
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax 0.07 -0.70 5.31
Reported Profit After Tax 96.46 13.71 27.73
Extra-ordinary Items 0.00 0.00 0.00
Adjusted Profit After Extra-ordinary item 96.46 13.71 27.73
EPS (Unit Curr.) 75.18 10.68 21.62
EPS (Adj) (Unit Curr.) 75.18 10.68 21.62
Calculated EPS (Unit Curr.) 74.77 10.63 21.50
Calculated EPS (Adj) (Unit Curr.) 74.77 10.63 21.50
Calculated EPS (Ann.) (Unit Curr.) 299.09 42.50 85.99
Calculated EPS (Adj) (Ann.) (Unit Curr.) 299.09 42.50 85.99
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 0.00 0.00 0.00
Equity 12.90 12.90 12.90
Reserve & Surplus 0.00 0.00 0.00
Face Value 10.00 10.00 10.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) 30.51 14.40 17.73
PBDTM(%) 29.47 12.83 17.01
PATM(%) 18.76 4.68 8.44